Commercial insurance enrollees pay less for ultra-expensive drugs than Medicare Part D members: Study
(By Rylee Wilson for Becker’s Hospital Review) Medicare Part D beneficiaries that don’t receive low-income subsidies spend 2.5 times more
Read More